Kotwica G, Franczak A, Okrasa S, Kotwica J
Department of Animal Physiology, University of Agriculture and Technology, Olsztyn-Kortowo, Poland.
Acta Vet Hung. 1999;47(2):249-62. doi: 10.1556/004.47.1999.2.10.
The role of oxytocin (OT) in the regulation of prostaglandin F2 alpha (PGF2 alpha) secretion during luteolysis in gilts was studied using a highly specific OT antagonist (CAP-581). In Experiment 1 gilts on Days 14 to 19 of the oestrous cycle in Latin square design were used, to determine the dose and time of application of OT and CAP. In Group I (n = 6) gilts were treated intravenously with saline or with 10, 20 and 30 IU of OT. Concentrations of the main PGF2 alpha metabolite i.e. 13,14-dihydro-15-keto-prostaglandin F2 alpha (PGFM) were measured in blood samples as uterine response to the treatment. Twenty IU of OT was the most effective to stimulate PGFM release and this dose was used after CAP treatment in gilts of Groups II, III and IV. Gilts of Group II (n = 3) were injected into the uterine horns (UH) with saline (5 ml/horn) or CAP (2 mg, 3 mg and 4 mg; half dose/horn) and OT was injected (i.v.) 30 min thereafter. Any of the CAP doses given into the UH affected PGFM plasma concentrations stimulated by OT. In Group III (n = 4) gilts were infused (i.v.) for 30 min with CAP (9 mg, 14 mg and 18 mg/gilt) followed by 20 IU of OT. All doses of CAP effectively inhibited OT-stimulated PGF2 alpha release, therefore 9 mg was selected for the further studies. Gilts of Group IV (n = 4) received OT 4, 6 and 8 h after CAP to define how long CAP blocks the OT receptors. Concentrations of PGFM increased after any of this period of time. Thus, we concluded that 9 mg of CAP infused every 4 h will effectively block OT receptors. In Experiment 2, gilts (n = 4) received CAP as a 30-min infusion every 4 h on Days 12-20 of the oestrous cycle. Control gilts (n = 3) were infused with saline. CAP infusions diminished the height of PGFM peaks (P < 0.05). Frequency of the PGFM (P < 0.057) and OT (P < 0.082) peaks only tended to be lower in the CAP-treated gilts. Peripheral plasma concentrations of progesterone (P4) and oestradiol-17 beta (E2) and the time of luteolysis initiation as measured by the decrease of P4 concentration were the same in CAP- and saline-treated gilts. The macroscopic studies of the ovaries in gilts revealed lack of differences between groups. We conclude that OT is involved in the secretion of luteolytic PGF2 alpha peaks but its role is limited to controlling their height and frequency. Blocking of OT receptors did not prevent luteolysis in sows.
利用一种高度特异性的催产素拮抗剂(CAP - 581)研究了催产素(OT)在后备母猪黄体溶解过程中对前列腺素F2α(PGF2α)分泌的调节作用。在实验1中,采用拉丁方设计,选用处于发情周期第14至19天的后备母猪,以确定OT和CAP的给药剂量及时间。在第一组(n = 6)中,给后备母猪静脉注射生理盐水或10、20和30国际单位的OT。作为子宫对治疗的反应,在血样中测量主要PGF2α代谢物即13,14 - 二氢 - 15 - 酮 - 前列腺素F2α(PGFM)的浓度。20国际单位的OT最有效地刺激了PGFM释放,该剂量在第二、三、四组后备母猪接受CAP治疗后使用。第二组(n = 3)的后备母猪子宫角(UH)注射生理盐水(5毫升/角)或CAP(2毫克、3毫克和4毫克;半剂量/角),30分钟后静脉注射OT。注入子宫角的任何一种CAP剂量都会影响OT刺激的PGFM血浆浓度。在第三组(n = 4)中,给后备母猪静脉输注CAP(9毫克、14毫克和18毫克/头)30分钟,随后注射20国际单位的OT。所有剂量的CAP均有效抑制OT刺激的PGF2α释放,因此选择9毫克用于进一步研究。第四组(n = 4)的后备母猪在接受CAP后4、6和8小时注射OT,以确定CAP阻断OT受体的时长。在此时间段内的任何时间后,PGFM浓度均升高。因此,我们得出结论,每4小时注入9毫克的CAP将有效阻断OT受体。在实验2中,在发情周期第12至20天,给后备母猪(n = 4)每4小时输注一次CAP,持续30分钟。对照后备母猪(n = 3)输注生理盐水。输注CAP降低了PGFM峰值的高度(P < 0.05)。在接受CAP治疗的后备母猪中,PGFM(P < 0.057)和OT(P < 0.082)峰值的频率仅趋于降低。CAP处理组和生理盐水处理组的后备母猪外周血中孕酮(P4)和雌二醇 - 17β(E2)的血浆浓度以及通过P4浓度下降测量的黄体溶解起始时间相同。对后备母猪卵巢的宏观研究表明,各组之间没有差异。我们得出结论,OT参与黄体溶解PGF2α峰值的分泌,但其作用仅限于控制峰值的高度和频率。阻断OT受体并不能防止母猪黄体溶解。